Biotinylated Anti-Human IGF-BP1
Catalog Number:
500-P228Bt
Preparation:
Produced from sera of rabbits immunized with highly pure recombinant Human IGF-BP1. Anti-Human IGF-BP1 specific antibody was purified by affinity chromatography and then biotinylated.
Immunogen:
E.coli derived Recombinant Human IGF-BP1 (PeproTech catalog #350-10)
Application:
ELISA
Direct
To detect hIGF-BP1 by direct ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hIGF-BP1. 

ELISA: Direct
 
Sandwich
To detect hIGF-BP1 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human IGF-BP1 (500-P228) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hIGF-BP1. 

 
Western Blot
To detect hIGF-BP1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-BP1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. 
Western Transfer (Western Blot)
 
 
 
 
 
Research Interests:
Apoptosis
Cancer
Diabetes / Weight Regulation
Proliferation
 
 
Country of Origin:
USA
Research Use Only. Not for use in diagnostic or therapeutic procedures.